Does OBINUTUZUMAB Cause Platelet count decreased? 361 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 361 reports of Platelet count decreased have been filed in association with OBINUTUZUMAB (Gazyva). This represents 2.5% of all adverse event reports for OBINUTUZUMAB.
361
Reports of Platelet count decreased with OBINUTUZUMAB
2.5%
of all OBINUTUZUMAB reports
42
Deaths
116
Hospitalizations
How Dangerous Is Platelet count decreased From OBINUTUZUMAB?
Of the 361 reports, 42 (11.6%) resulted in death, 116 (32.1%) required hospitalization, and 8 (2.2%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
Yes, Platelet count decreased is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which OBINUTUZUMAB Alternatives Have Lower Platelet count decreased Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE